• Olga Yu Fedorenko
  • Vera E. Golimbet
  • Arkady V. Semke
  • German G. Simutkin
  • Аnna E. Gareeva
  • Anna Gryaznova
  • Ivan Y. Iourov
  • Evgeny M. Krupitsky
  • Igor N. Lebedev
  • Galina E. Mazo
  • Vasily G. Kaleda
  • Lilia I. Abramova
  • Igor V. Oleichik
  • Regina F. Nasyrova
  • Anton E. Nikolishin
  • Evgeny D. Kasyanov
  • Grigory V. Rukavishnikov
  • Ilgiz F. Timerbulatov
  • Vadim M. Brodyansky
  • Svetlana G. Vorsanova
  • Yury B. Yurov
  • Tatyana V. Zhilyaeva
  • Anzhelika V. Sergeeva
  • Elena A. Blokhina
  • Edwin E. Zvartau
  • Anna S. Blagonravova
  • Lyubomir I. Aftanas
  • Nikolay Bokhan
  • Zurab I. Kekelidze
  • Tatyana V. Klimenko
  • Irina P. Anokhina
  • Elza K. Khusnutdinova
  • Tatyana P. Klyushnik
  • Nikolay G. Neznanov
  • Vadim A. Stepanov
  • Thomas G. Schulze
  • Аleksandr Kibitov

We provide an overview of the recent achievements in psychiatric genetics research in the Russian Federation and present genotype-phenotype, population, epigenetic, cytogenetic, functional, ENIGMA, and pharmacogenetic studies, with an emphasis on genome-wide association studies. The genetic backgrounds of mental illnesses in the polyethnic and multicultural population of the Russian Federation are still understudied. Furthermore, genetic, genomic, and pharmacogenetic data from the Russian Federation are not adequately represented in the international scientific literature, are currently not available for meta-analyses and have never been compared with data from other populations. Most of these problems cannot be solved by individual centers working in isolation but warrant a truly collaborative effort that brings together all the major psychiatric genetic research centers in the Russian Federation in a national consortium. For this reason, we have established the Russian National Consortium for Psychiatric Genetics (RNCPG) with the aim to strengthen the power and rigor of psychiatric genetics research in the Russian Federation and enhance the international compatibility of this research. The consortium is set up as an open organization that will facilitate collaborations on complex biomedical research projects in human mental health in the Russian Federation and abroad. These projects will include genotyping, sequencing, transcriptome and epigenome analysis, metabolomics, and a wide array of other state-of-the-art analyses. Here, we discuss the challenges we face and the approaches we will take to unlock the huge potential that the Russian Federation holds for the worldwide psychiatric genetics community.

Original languageEnglish
Pages (from-to)1099-1111
Number of pages13
JournalMolecular Psychiatry
Volume24
Issue number8
Early online date1 Jan 2019
DOIs
StatePublished - 1 Aug 2019

    Research areas

  • ALZHEIMERS-DISEASE, PHARMACOGENETIC MARKERS, PARANOID SCHIZOPHRENIA, TARDIVE-DYSKINESIA, RECEPTOR GENES, POLYMORPHISM, ASSOCIATION, BRAIN, ANEUPLOIDY, DRUG

    Scopus subject areas

  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Molecular Biology

ID: 38194977